Table 1 Literature review-based data that were used to populate the projection models
From: The emerging epidemic of inflammatory bowel disease in Asia and Iran by 2035: A modeling study
Region(country) | Incidence rate | Prevalence(95% UI) | Death rate due to IBD (95% UI) | The death rate due to other causes(95% UI) |
|---|---|---|---|---|
Iran | 3.11 | 27.0 (24.6–29.6) | 0.16 (0.06–0.19) | 463.97 (452.58–477.04) |
High‐income Asia‐Pacific | 2.784 | 36.4 (33.7–39.3) | 0.37 (0.3–0.49) | 931.03 (921.89–940.28) |
East Asia | 1.541 | 134.6 (123.9–145.6) | 0.34 (0.28–0.39) | 752.33 (661.03–848.26) |
Southeast Asia | 0.804 | 15.3 (13.9–16.8) | 0.22 (0.17–0.26) | 651.29 (604–721.04) |
North Africa and Middle East | 3.121 | 29.6 (26.2–33.8) | 0.17 (0.14–0.2) | 509.71 (462.58–561.06) |
South Asia (India) | 8.133 | 16.2 (14.7–17.9) | 0.3 (0.21–0.4) | 675.31 (606.15–749.66) |